TGFB1 and neoplasm: Of particular note, there is a broad consensus that TGF-b containing tumor exosomes are capable of driving down NKG2D levels on NK cells comparable to that seen for soluble TGF-b, whereas neutralizing antibodies against TGF-b can restore the observed effects [23, 64, 78, 85, 116].